Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2,816,000 | 2,761,000 | 2,652,000 | 2,621,000 | 2,488,000 |
| Cost of Goods | 1,867,000 | 1,818,000 | 1,789,000 | 1,763,000 | 1,677,000 |
| Gross Profit | 949,000 | 943,000 | 863,000 | 858,000 | 811,000 |
| Operating Expenses | 563,000 | 505,000 | 517,000 | 497,000 | 481,000 |
| Operating Income | 386,000 | 438,000 | 346,000 | 361,000 | 330,000 |
| Interest Expense | 66,000 | 67,000 | 67,000 | 65,000 | 49,000 |
| Other Income | 16,000 | 22,000 | 15,000 | 8,000 | 21,000 |
| Pre-tax Income | 336,000 | 393,000 | 294,000 | 304,000 | 302,000 |
| Income Tax | 77,000 | 97,000 | 59,000 | 68,000 | 65,000 |
| Net Income Continuous | 259,000 | 296,000 | 235,000 | 236,000 | 237,000 |
| Minority Interests | 14,000 | 14,000 | 15,000 | 14,000 | 11,000 |
| Net Income | $245,000 | $282,000 | $220,000 | $222,000 | $226,000 |
| EPS Basic Total Ops | 2.18 | 2.51 | 1.97 | 1.98 | 2.01 |
| EPS Basic Continuous Ops | 2.31 | 2.64 | 2.12 | 2.15 | 2.12 |
| EPS Diluted Total Ops | 2.16 | 2.47 | 1.94 | 1.95 | 1.99 |
| EPS Diluted Continuous Ops | 2.29 | 2.62 | 2.08 | 2.05 | 2.10 |
| EPS Diluted Before Non-Recurring Items | 2.60 | 2.62 | 2.21 | 2.23 | 2.30 |
| EBITDA(a) | $528,000 | $581,000 | $486,000 | $496,000 | $455,000 |